← The Wire
ABUSNasdaq
Arbutus Biopharma Corp
Pharmaceutical Preparations · A1 · CIK 1447028
Develops RNAi therapeutics for chronic hepatitis B and defends its lipid nanoparticle technology
red 8-K · 90d
$842M
Market cap
$4.68
Last close
+2.2%
1D
+3.5%
5D
2.5M
Volume
Price · last 39 sessions+6.6%
May 4L $4.12 · H $4.68Jun 29
555
Total filings
May 27, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteMay 27, 202610-Q10-QMay 13, 20268-KResults of OperationsMay 13, 2026SC 13D/ASC 13D/AApr 28, 20268-KCompany UpdateApr 15, 2026DEFA14ADEFA14AApr 14, 2026DEF 14ADEF 14AApr 14, 2026SC 13D/ASC 13D/AApr 13, 20268-KResults of OperationsMar 23, 202610-K10-KMar 23, 20268-KMaterial Agreement · Company UpdateMar 3, 20268-KCompany UpdateFeb 20, 20268-KCompany UpdateFeb 6, 20268-KCompany UpdateJan 16, 20268-KCompany UpdateDec 11, 20258-KResults of Operations · Company UpdateNov 13, 202510-Q10-QNov 13, 20258-KCompany UpdateOct 7, 20258-KCompany UpdateSep 10, 202510-Q10-QAug 6, 20258-KExecutive Change · Results of OperationsAug 6, 20258-KAgreement Terminated · Company UpdateJun 25, 20258-KShareholder VoteMay 23, 202510-Q10-QMay 14, 20258-KResults of OperationsMay 14, 20258-KCompany UpdateMay 7, 20258-KCompany UpdateApr 23, 2025DEFA14ADEFA14AApr 4, 2025DEF 14ADEF 14AApr 4, 20258-KExecutive Change · Company UpdateApr 3, 202510-K10-KMar 27, 20258-KResults of OperationsMar 27, 20258-KMaterial Agreement · Company UpdateMar 3, 20258-KExecutive Change · Company UpdateFeb 25, 20258-KResults of Operations · Company UpdateJan 13, 20258-KCompany UpdateNov 15, 202410-Q10-QNov 6, 20248-KResults of Operations · Company UpdateNov 6, 20248-KCompany UpdateOct 15, 20248-KExecutive ChangeOct 11, 202410-Q10-QAug 8, 20248-KReg FD DisclosureAug 5, 20248-KResults of Operations · Company UpdateAug 1, 2024SC 13GMS INITIALJun 10, 20248-KCompany UpdateJun 6, 20248-KCompany UpdateJun 5, 20248-KExecutive Change · Shareholder VoteMay 28, 20248-KCompany UpdateMay 22, 2024SC 13DTHE SCHEDULE 13DMay 9, 202410-Q10-QMay 2, 20248-KResults of Operations · Company UpdateMay 2, 20248-KExecutive Change · Company UpdateMay 2, 2024DEFA14ADEFA14AApr 10, 2024DEF 14ADEF 14AApr 10, 20248-KCompany UpdateApr 4, 202410-K10-KMar 5, 20248-KResults of Operations · Company UpdateFeb 29, 20248-KResults of Operations · Company UpdateJan 8, 20248-KExecutive ChangeJan 4, 2024SC 13GSC 13GNov 21, 20238-KCompany UpdateNov 9, 202310-Q10-QNov 7, 20238-KResults of Operations · Company UpdateNov 7, 20238-KExecutive ChangeNov 7, 20238-KCompany UpdateOct 11, 2023SC 13GSC 13GSep 11, 20238-KCompany UpdateSep 11, 202310-Q10-QAug 3, 20238-KResults of Operations · Company UpdateAug 3, 20238-KExecutive ChangeJul 12, 20238-KCompany UpdateJul 10, 20238-KCompany UpdateJun 21, 20238-KCompany UpdateJun 21, 20238-KCompany UpdateJun 7, 20238-KShareholder VoteMay 30, 202310-Q10-QMay 4, 20238-KResults of Operations · Company UpdateMay 4, 20238-KCompany UpdateApr 27, 20238-KCompany UpdateApr 25, 20238-KCompany UpdateApr 18, 2023
Similar companies
Comparable business profile · signals at a glance